المؤلفون: Bisson GP; Department of Medicine and Department of Biostatistics, Epidemiology, and Informatics, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, PA, USA. Electronic address: bisson@pennmedicine.upenn.edu., Bastos M; Social Medicine Institute, State University of Rio de Janeiro, Rio de Janeiro, Brazil; Department of Epidemiology, Biostatistics, and Occupational Health, McGill University, Montreal, QC, Canada., Campbell JR; Department of Epidemiology, Biostatistics, and Occupational Health, McGill University, Montreal, QC, Canada., Bang D; Virus & Microbiological Special Diagnostics, Statens Serum Institut, Copenhagen, Denmark., Brust JC; Department of Medicine, Albert Einstein College of Medicine, New York, NY, USA., Isaakidis P; Médecins Sans Frontières, Cape Town, South Africa., Lange C; Division of Clinical Infectious Diseases, Research Center Borstel, Borstel, Germany., Menzies D; Department of Epidemiology, Biostatistics, and Occupational Health, McGill University, Montreal, QC, Canada., Migliori GB; WHO Collaborating Centre for TB and Lung Diseases, Maugeri Care and Research Institute, Tradate, Italy., Pape JW; Weill Cornell Medicine, New York, NY, USA., Palmero D; División Neumotisiología, Hospital Muñiz, Buenos Aires, Argentina., Baghaei P; Clinical Tuberculosis and Epidemiology Research Center National Research Institute for Tuberculosis and Lung Disease, Shahid Beheshti University of Medical Sciences, Tehran, Iran., Tabarsi P; Clinical Tuberculosis and Epidemiology Research Center National Research Institute for Tuberculosis and Lung Disease, Shahid Beheshti University of Medical Sciences, Tehran, Iran., Viiklepp P; National Institute of Health Development, Tallinn, Estonia., Vilbrun S; Groupe Haitien d'Étude du Sarcome de Kaposi et des infections Opportunistes, Port-au-Prince, Haiti., Walsh J; Department of Medicine and Department of Biostatistics, Epidemiology, and Informatics, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, PA, USA., Marks SM; Centers for Disease Control and Prevention, Atlanta, GA, USA.

المصدر: Lancet (London, England) [Lancet] 2020 Aug 08; Vol. 396 (10248), pp. 402-411.

نوع المنشور: Journal Article; Meta-Analysis

بيانات الدورية: Publisher: Elsevier Country of Publication: England NLM ID: 2985213R Publication Model: Print Cited Medium: Internet ISSN: 1474-547X (Electronic) Linking ISSN: 01406736 NLM ISO Abbreviation: Lancet Subsets: MEDLINE

مواضيع طبية MeSH: Anti-HIV Agents/*therapeutic use , Antitubercular Agents/*therapeutic use , HIV Infections/*drug therapy , HIV Infections/*mortality , Tuberculosis, Multidrug-Resistant/*drug therapy , Tuberculosis, Multidrug-Resistant/*mortality, Adult ; Female ; HIV Infections/complications ; Humans ; Male ; Risk Factors ; Tuberculosis, Multidrug-Resistant/complications

المؤلفون: Ahmad N; Faculty of Pharmacy and Health Sciences, University of Baluchistan, Quetta, Pakistan., Ahuja SD; Bureau of Tuberculosis Control, New York City Department of Health and Mental Hygiene, NY, USA., Akkerman OW; Department of Pulmonary Diseases and Tuberculosis, University of Groningen, University Medical Centre Groningen, Groningen, Netherlands; Tuberculosis Centre Beatrixoord, University of Groningen, University Medical Centre Groningen, Groningen, Netherlands., Alffenaar JC; Department of Clinical Pharmacy and Pharmacology, University of Groningen, University Medical Centre Groningen, Groningen, Netherlands., Anderson LF; Global Tuberculosis Program, World Health Organization, Geneva, Switzerland., Baghaei P; Clinical Tuberculosis and Epidemiology Research Center, NRITLD, Shahid Beheshti University of Medical Sciences, Tehran, Iran., Bang D; Statens Serum Institut, Copenhagen, Denmark., Barry PM; Tuberculosis Control Branch, Division of Communicable Disease Control, Center for Infectious Diseases, California Department of Public Health, CA, USA., Bastos ML; Social Medicine Institute, Epidemiology Department, State University of Rio de Janeiro, Rio de Janeiro, Brazil., Behera D; Department of Pulmonary Medicine, World Health Organization Collaborating Centre for Research & Capacity Building in Chronic Respiratory Diseases, Chandigarh, India; Postgraduate Institute of Medical Education & Research, Chandigarh, India., Benedetti A; Montreal Chest Institute, McGill University Health Center Research Institute, McGill University, Montreal, QC, Canada., Bisson GP; University of Pennsylvania, Perelman School of Medicine, Philadelphia, PA, USA., Boeree MJ; Department of Pulmonary Diseases, Radboud University Medicale Centre Nijmegen and Dekkerswald Radboudumc Groesbeek, Netherlands., Bonnet M; Epicentre MSF, Paris, France; Institut de Recherche pour le Développement UM233, INSERM U1175, Université de Montpellier, Montpellier, France., Brode SK; Department of Medicine, Division of Respirology, University of Toronto, West Park Healthcare Centre, University Health Network, and Sinai Health System, Toronto, ON, Canada., Brust JCM; Division of General Internal Medicine and Division of Infectious Diseases, Montefiore Medical Center, Albert Einstein College of Medicine, New York, NY, USA., Cai Y; Tuberculosis Research Section, Laboratory of Clinical Immunology and Microbiology, National Institute of Allergy and Infectious Diseases, US National Institutes of Health, Bethesda, MD, USA., Caumes E; AP-HP, Service des Maladies Infectieuses et Tropicales, Hôpitaux Universitaires Pitié Salpêtrière-Charles Foix, Paris, France., Cegielski JP; Division of Global HIV and TB, Centers for Disease Control and Prevention, Atlanta, GA, USA., Centis R; World Health Organization Collaborating Centre for Tuberculosis and Lung Diseases, Maugeri Care and Research Institute, Tradate, Italy., Chan PC; Division of Chronic Infectious Diseases, Taiwan Centers for Disease Control, Taipei, Taiwan., Chan ED; Department of Medicine, University of Colorado Denver, Aurora, CO, USA; Department of Medicine, National Jewish Health, Denver, CO, USA; VA Medical Center, Denver, CO, USA., Chang KC; Department of Health, Tuberculosis and Chest Service, Centre for Health Protection, Hong Kong Special Administrative Region, China., Charles M; Centers for Disease Control and Prevention, Haiti Country Office, Port-au-Prince, Haiti., Cirule A; Centre of TB and Lung Diseases, Riga East University Hospital, Riga, Latvia., Dalcolmo MP; Centro de Referência Helio Fraga, Fiocruz, Brazil., D'Ambrosio L; World Health Organization Collaborating Centre for Tuberculosis and Lung Diseases, Maugeri Care and Research Institute, Tradate, Italy; Public Health Consulting Group, Lugano, Switzerland., de Vries G; Centre for Infectious Disease Control, National Institute for Public Health and the Environment (RIVM), Bilthoven, Netherlands; KNCV Tuberculosis Foundation, The Hague, Netherlands., Dheda K; Centre for Lung Infection and Immunity, Department of Medicine & UCT Lung Institute, University of Cape Town, Cape Town, South Africa., Esmail A; Centre for Lung Infection and Immunity, Department of Medicine & UCT Lung Institute, University of Cape Town, Cape Town, South Africa., Flood J; Tuberculosis Control Branch, Division of Communicable Disease Control, Center for Infectious Diseases, California Department of Public Health, CA, USA., Fox GJ; Sydney Medical School, University of Sydney, NSW, Australia., Fréchet-Jachym M; Sanatorium, Centre Hospitalier de Bligny, Briis-sous-Forges, France., Fregona G; University Federal of Espirito Santo, Vitória, Brazil., Gayoso R; Centro de Referência Helio Fraga, Fiocruz, Brazil., Gegia M; Global Tuberculosis Program, World Health Organization, Geneva, Switzerland., Gler MT; Tropical Disease Foundation, Manila, Philippines., Gu S; Department of Medicine, University of Colorado Denver, Aurora, CO, USA., Guglielmetti L; AP-HP, Laboratoire de Bactériologie-Hygiène, Centre National de Référence des Mycobactéries et de la Résistance des Mycobactéries aux Antituberculeux, Hôpitaux Universitaires Pitié Salpêtrière-Charles Foix, Paris, France; Sorbonne Université, Centre d'Immunologie et des Maladies Infectieuses (CIMI; INSERM U1135/UMRS CR7/CNRS ERL 8255), Bactériologie, Faculté de Médecine Sorbonne Université, Paris, France; Sanatorium, Centre Hospitalier de Bligny, Briis-sous-Forges, France., Holtz TH; Division of Global HIV and TB, Centers for Disease Control and Prevention, Atlanta, GA, USA., Hughes J; Médecins Sans Frontières, Khayelitsha, South Africa., Isaakidis P; Médecins Sans Frontières, Mumbai, India., Jarlsberg L; Division of Pulmonary and Critical Care Medicine, University of California, San Francisco, CA, USA., Kempker RR; Emory University School of Medicine, Division of Infectious Diseases, Atlanta, GA, USA., Keshavjee S; Department of Global Health and Social Medicine, Harvard Medical School, Boston, MA, USA; Division of Global Health Equity, Brigham and Women's Hospital, Boston, MA, USA., Khan FA; Montreal Chest Institute, McGill University Health Center Research Institute, McGill University, Montreal, QC, Canada., Kipiani M; National Center for Tuberculosis and Lung Diseases, Tbilisi, Georgia., Koenig SP; Division of Global Health Equity, Brigham and Women's Hospital, Boston, MA, USA; Haitian Study Group for Kaposi's Sarcoma and Opportunistic Infections (GHESKIO), Port-au-Prince, Haiti., Koh WJ; Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, South Korea., Kritski A; Academic Tuberculosis Program, School of Medicine, Federal University of Rio de Janeiro, Rio de Janeiro, Brazil., Kuksa L; Department of MDR TB, Riga East University Hospital, Riga, Latvia., Kvasnovsky CL; Division of Pediatric Surgery, Cohen Children's Medical Center, Hofstra Northwell School of Medicine, New Hyde Park, NY, USA., Kwak N; Department of Internal Medicine, Division of Pulmonary and Critical Care Medicine, Seoul National University College of Medicine, Seoul, South Korea., Lan Z; Montreal Chest Institute, McGill University Health Center Research Institute, McGill University, Montreal, QC, Canada., Lange C; Division of Clinical Infectious Diseases, Research Center Borstel, Germany; German Center for Infection Research, Clinical Tuberculosis Unit, Borstel, Germany; International Health/Infectious Diseases, University of Luebeck, Luebeck, Germany; Department of Medicine, Karolinska Institute, Stockholm, Sweden., Laniado-Laborín R; Tuberculosis Clinic and Laboratory, Tijuana General Hospital, Tijuana, Mexico., Lee M; Clinical Research Section, International Tuberculosis Research Centre, Seoul, South Korea., Leimane V; Centre of TB and Lung Diseases, Riga East University Hospital, Riga, Latvia., Leung CC; Department of Health, Tuberculosis and Chest Service, Centre for Health Protection, Hong Kong Special Administrative Region, China., Leung EC; Department of Health, Tuberculosis and Chest Service, Centre for Health Protection, Hong Kong Special Administrative Region, China., Li PZ; Montreal Chest Institute, McGill University Health Center Research Institute, McGill University, Montreal, QC, Canada., Lowenthal P; Tuberculosis Control Branch, Division of Communicable Disease Control, Center for Infectious Diseases, California Department of Public Health, CA, USA., Maciel EL; University Federal of Espirito Santo, Vitória, Brazil., Marks SM; Division of Tuberculosis Elimination, Centers for Disease Control and Prevention, Atlanta, GA, USA., Mase S; Division of Tuberculosis Elimination, Centers for Disease Control and Prevention, Atlanta, GA, USA; Regional WHO Office, New Delhi, India., Mbuagbaw L; Department of Health Research Methods, Evidence and Impact, McMaster University, Hamilton, ON, Canada; Biostatistics Unit, Father Sean O'Sullivan Research Centre, St Joseph's Healthcare Hamilton, Hamilton, ON, Canada., Migliori GB; World Health Organization Collaborating Centre for Tuberculosis and Lung Diseases, Maugeri Care and Research Institute, Tradate, Italy., Milanov V; Medical Faculty, Medical University-Sofia, University Hospital for Respiratory Diseases 'St. Sofia', Sofia, Bulgaria., Miller AC; Department of Global Health and Social Medicine, Harvard Medical School, Boston, MA, USA., Mitnick CD; Department of Global Health and Social Medicine, Harvard Medical School, Boston, MA, USA., Modongo C; Botswana-UPenn Partnership, Gaborone, Botswana., Mohr E; Médecins Sans Frontières, Khayelitsha, South Africa., Monedero I; TB-HIV Department, International Union against Tuberculosis and Lung Diseases, Paris, France., Nahid P; Division of Pulmonary and Critical Care Medicine, University of California, San Francisco, CA, USA., Ndjeka N; National TB Programme, South African National Department of Health, Pretoria, South Africa., O'Donnell MR; Division of Pulmonary, Allergy, and Critical Care Medicine, Columbia University Medical Center, New York, NY, USA; Department of Epidemiology, Mailman School of Public Health, Columbia University, New York, NY, USA., Padayatchi N; CAPRISA, MRC TB-HIV Treatment and Pathogenesis Research Unit, Durban, South Africa., Palmero D; Pulmonology Division, Municipal Hospital F J Munĩz, Buenos Aires, Argentina., Pape JW; Haitian Study Group for Kaposi's Sarcoma and Opportunistic Infections (GHESKIO), Port-au-Prince, Haiti; Center for Global Health, Department of Medicine, Weill Cornell Medical College, New York, NY, USA., Podewils LJ; Division of Global HIV and TB, Centers for Disease Control and Prevention, Atlanta, GA, USA., Reynolds I; Department of Medicine, University of Colorado Denver, Aurora, CO, USA., Riekstina V; Centre of TB and Lung Diseases, Riga East University Hospital, Riga, Latvia., Robert J; AP-HP, Laboratoire de Bactériologie-Hygiène, Centre National de Référence des Mycobactéries et de la Résistance des Mycobactéries aux Antituberculeux, Hôpitaux Universitaires Pitié Salpêtrière-Charles Foix, Paris, France; Sorbonne Université, Centre d'Immunologie et des Maladies Infectieuses (CIMI; INSERM U1135/UMRS CR7/CNRS ERL 8255), Bactériologie, Faculté de Médecine Sorbonne Université, Paris, France., Rodriguez M; National Tuberculosis Control Program, Dominican Republic., Seaworth B; Heartland National TB Center, University of Texas Health Science Center at Tyler, Tyler, TX, USA., Seung KJ; Partners In Health, Boston, MA, USA., Schnippel K; Faculty of Health Sciences, School of Public Health and Family Medicine, University of Cape Town, Cape Town, South Africa., Shim TS; Department of Pulmonary and Critical Care Medicine, University of Ulsan College of Medicine, Seoul, South Korea., Singla R; National Institute of Tuberculosis & Respiratory Diseases, New Delhi, India., Smith SE; Division of Global HIV and TB, Centers for Disease Control and Prevention, Atlanta, GA, USA., Sotgiu G; Department of Medical, Surgical and Experimental Sciences, Clinical Epidemiology and Medical Statistics Unit, University of Sassari, Sassari, Italy., Sukhbaatar G; Ministry of Health of Mongolia, Mongolia., Tabarsi P; Clinical Tuberculosis and Epidemiology Research Center, NRITLD, Shahid Beheshti University of Medical Sciences, Tehran, Iran., Tiberi S; Royal London Hospital, Barts Health NHS Trust, London, UK; Blizard Institute, Barts and The London School of Medicine and Dentistry, Queen Mary University of London, London, UK., Trajman A; Social Medicine Institute, Epidemiology Department, State University of Rio de Janeiro, Rio de Janeiro, Brazil; Montreal Chest Institute, McGill University Health Center Research Institute, McGill University, Montreal, QC, Canada; Academic Tuberculosis Program, School of Medicine, Federal University of Rio de Janeiro, Rio de Janeiro, Brazil., Trieu L; Bureau of Tuberculosis Control, New York City Department of Health and Mental Hygiene, NY, USA., Udwadia ZF; Hinduja Hospital & Research Center, Mumbai, India., van der Werf TS; Department of Pulmonary Diseases and Tuberculosis, University of Groningen, University Medical Centre Groningen, Groningen, Netherlands; Department of Internal Medicine/Infectious Diseases, University of Groningen, University Medical Centre Groningen, Groningen, Netherlands., Veziris N; AP-HP, Laboratoire de Bactériologie-Hygiène, Centre National de Référence des Mycobactéries et de la Résistance des Mycobactéries aux Antituberculeux, Hôpitaux Universitaires Pitié Salpêtrière-Charles Foix, Paris, France; Sorbonne Université, Centre d'Immunologie et des Maladies Infectieuses (CIMI; INSERM U1135/UMRS CR7/CNRS ERL 8255), Bactériologie, Faculté de Médecine Sorbonne Université, Paris, France., Viiklepp P; Estonian Tuberculosis Registry, National Institute for Health Development, Tallinn, Estonia., Vilbrun SC; Haitian Study Group for Kaposi's Sarcoma and Opportunistic Infections (GHESKIO), Port-au-Prince, Haiti., Walsh K; Haitian Study Group for Kaposi's Sarcoma and Opportunistic Infections (GHESKIO), Port-au-Prince, Haiti., Westenhouse J; Tuberculosis Control Branch, Division of Communicable Disease Control, Center for Infectious Diseases, California Department of Public Health, CA, USA., Yew WW; Stanley Ho Centre for Emerging Infectious Diseases, The Chinese University of Hong Kong, Hong Kong Special Administrative Region, China., Yim JJ; Department of Internal Medicine, Division of Pulmonary and Critical Care Medicine, Seoul National University College of Medicine, Seoul, South Korea., Zetola NM; Botswana-UPenn Partnership, Gaborone, Botswana., Zignol M; Global Tuberculosis Program, World Health Organization, Geneva, Switzerland., Menzies D; Montreal Chest Institute, McGill University Health Center Research Institute, McGill University, Montreal, QC, Canada. Electronic address: dick.menzies@mcgill.ca.

مؤلفون مشاركون: Collaborative Group for the Meta-Analysis of Individual Patient Data in MDR-TB treatment–2017

المصدر: Lancet (London, England) [Lancet] 2018 Sep 08; Vol. 392 (10150), pp. 821-834.

نوع المنشور: Journal Article; Meta-Analysis; Research Support, Non-U.S. Gov't; Review

بيانات الدورية: Publisher: Elsevier Country of Publication: England NLM ID: 2985213R Publication Model: Print Cited Medium: Internet ISSN: 1474-547X (Electronic) Linking ISSN: 01406736 NLM ISO Abbreviation: Lancet Subsets: MEDLINE

مواضيع طبية MeSH: Antitubercular Agents/*therapeutic use , Tuberculosis, Multidrug-Resistant/*drug therapy , Tuberculosis, Multidrug-Resistant/*mortality , Tuberculosis, Pulmonary/*drug therapy , Tuberculosis, Pulmonary/*mortality, Amikacin/therapeutic use ; Antitubercular Agents/administration & dosage ; Capreomycin/therapeutic use ; Carbapenems/therapeutic use ; Clofazimine/therapeutic use ; Diarylquinolines/therapeutic use ; Drug Therapy, Combination ; Fluoroquinolones/therapeutic use ; Humans ; Kanamycin/therapeutic use ; Levofloxacin/therapeutic use ; Linezolid/therapeutic use ; Moxifloxacin ; Recurrence ; Treatment Failure

المؤلفون: Schreiber S; Helen Wills Neuroscience Institute, University of California, Berkeley, CA, USA; Department of Neurology, Otto-von-Guericke University, Magdeburg, Germany; German Center for Neurodegenerative Diseases (DZNE), Magdeburg, Germany. Electronic address: stefanie.schreiber@med.ovgu.de., Vogel J; Helen Wills Neuroscience Institute, University of California, Berkeley, CA, USA., Schwimmer HD; Helen Wills Neuroscience Institute, University of California, Berkeley, CA, USA., Marks SM; Helen Wills Neuroscience Institute, University of California, Berkeley, CA, USA., Schreiber F; Department of Control Engineering, Technische Universität Braunschweig, Braunschweig, Germany., Jagust W; Helen Wills Neuroscience Institute, University of California, Berkeley, CA, USA; Life Sciences Division, Lawrence Berkeley National Laboratory, Berkeley, CA, USA.

المصدر: Neurobiology of aging [Neurobiol Aging] 2016 Apr; Vol. 40, pp. 164-172. Date of Electronic Publication: 2016 Jan 30.

نوع المنشور: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't

بيانات الدورية: Publisher: Elsevier Country of Publication: United States NLM ID: 8100437 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1558-1497 (Electronic) Linking ISSN: 01974580 NLM ISO Abbreviation: Neurobiol Aging Subsets: MEDLINE

مواضيع طبية MeSH: Cognition* , Healthy Lifestyle* , Life Style*, Hippocampus/*diagnostic imaging , Hippocampus/*physiology, Aged ; Amyloid beta-Peptides/metabolism ; Apolipoprotein E4/genetics ; Female ; Heterozygote ; Hippocampus/metabolism ; Hippocampus/pathology ; Humans ; Male ; Middle Aged ; Positron-Emission Tomography ; Risk

المؤلفون: Coulter IC; Department of Neurosurgery, James Cook University Hospital, Middlesbrough, UK. Electronic address: ian.coulter@doctors.org.uk., Khan SA; Department of Neurosurgery, James Cook University Hospital, Middlesbrough, UK., Flanagan AM; Department of Histopathology, Royal National Orthopaedic Hospital NHS Trust & University College Hospital, London, UK., Marks SM; Department of Neurosurgery, James Cook University Hospital, Middlesbrough, UK.

المصدر: Clinical neurology and neurosurgery [Clin Neurol Neurosurg] 2014 Jan; Vol. 116, pp. 83-6. Date of Electronic Publication: 2013 Nov 16.

نوع المنشور: Case Reports; Journal Article

بيانات الدورية: Publisher: Elsevier Country of Publication: Netherlands NLM ID: 7502039 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1872-6968 (Electronic) Linking ISSN: 03038467 NLM ISO Abbreviation: Clin Neurol Neurosurg Subsets: MEDLINE

مواضيع طبية MeSH: Arnold-Chiari Malformation/*surgery , Osteolysis, Essential/*surgery , Skull Base/*surgery, Adult ; Arnold-Chiari Malformation/etiology ; Arnold-Chiari Malformation/pathology ; Diagnosis, Differential ; Female ; Humans ; Osteolysis, Essential/complications ; Osteolysis, Essential/diagnosis ; Osteolysis, Essential/pathology ; Skull Base/pathology ; Treatment Outcome

المؤلفون: Marks SM, Yanovich S, Rosenthal DS, Moloney WC, Schlossman SF

المصدر: Blood [Blood] 1978 Mar; Vol. 51 (3), pp. 435-8.

نوع المنشور: Case Reports; Journal Article; Research Support, U.S. Gov't, P.H.S.

بيانات الدورية: Publisher: Elsevier Country of Publication: United States NLM ID: 7603509 Publication Model: Print Cited Medium: Print ISSN: 0006-4971 (Print) Linking ISSN: 00064971 NLM ISO Abbreviation: Blood Subsets: MEDLINE

مواضيع طبية MeSH: Leukemia, Lymphoid/*immunology , T-Lymphocytes/*immunology, Acid Phosphatase/metabolism ; Aged ; Fluorescent Antibody Technique ; Humans ; Male ; Periodic Acid-Schiff Reaction ; Rosette Formation ; Tartrates/metabolism